Clinical effectiveness of osteoporosis treatment in older patients: A fracture liaison service-based prospective study

References

• Ahmed, L., Center, A., Bjørnerem, A., Bluic, D., Joakimsen, R., Jørgensen, L., & Emaus, N. (2013). Progressively increasing fracture risk with advancing age after initial incident fragility fracture: The Tromsø Study. Journal of Bone and Mineral Research, 28, 2214–2221. doi:10.1002/jbmr.1952
   PubMed Web of Science ®Google Scholar
• Åkesson, K., Marsh, D., Mitchell, P. J., McLellan, A. R., Stenmark, J., Pierroz, D. D., & Cooper, C. (2013). Capture the fracture: A Best Practice Framework and global campaigne to break the fragility fracture cycle. Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 24, 2135–2152. doi:10.1007/s00198-013-2348-z
   PubMed Web of Science ®Google Scholar
• Axelsson, K. F., Jacobsson, R., Lund, D., & Lorentzon, M. (2016). Effectiveness of a minimal resource fracture liaison service. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27, 3165–3175. doi:10.1007/s00198-016-3643-2
   PubMed Web of Science ®Google Scholar
• Boonen, S., Black, D., Colón-Emeric, C., Eastell, R., Magaziner, J., Eriksen, E. F., & Lyles, K. (2010). Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. Journal of the American Geriatrics Society, 58, 292–299. doi:10.1111/j.1532-5415.2010.03135.x
   PubMed Web of Science ®Google Scholar
• Boonen, S., McClung, M. R., Eastell, R., El-Hajj Fuleihan, G., Barton, I. P., & Delmas, P. (2004). Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: Implications for the use of antiresorptive agents in the old and oldest old. Journal of the American Geriatrics Society, 52, 1832–1839. doi:10.1111/j.1532-5415.2004.52506.x
   PubMed Web of Science ®Google Scholar
• Briot, K., Roux, C., Thomas, T., Blain, H., Buchon, D., Chapurlat, R., & Cortet, B. (2018). 2018 update of French recommendations on the management of postmenopausal osteoporosis. Joint Bone Spine. doi:10.1016/j.jbspin.2018.02.009 [Epub ahead of print].
   Google Scholar
• Cummings, S. R., & Melton, L. J. (2002). Epidemiology and outcomes of osteoporotic fractures. Lancet, 359, 1761–1767. doi:10.1016/S0140-6736(02)08657-9
   PubMed Web of Science ®Google Scholar
• Curtis, J. R., & Safford, M. (2012). Management of Osteoporosis among the elderly with other chronic medical conditions. Drugs Aging, 29, 549–564. doi:10.2165/11599620-000000000-00000
   PubMed Web of Science ®Google Scholar
• de Bruin, I., Wyers, C., van Den Bergh, J., & Geusens, P. (2017). Fracture liaison services: Do they reduce fracture rates? Therapeutics Advancement Musculoskel Diseases, 9, 157–164. doi:10.1177/1759720X17706464
   PubMed Web of Science ®Google Scholar
• Eisman, J., Bogoch, E., Dell, R., Harrington, T., McKinney, R., Jr., McLellan, A., & Siris, E. (2012). Making the first fracture the last fracture: ASBMR Task Force report on secondary fracture prevention. Jbmr, 27, 2039–2046. doi:10.1002/jbmr.1698
   Google Scholar
• Elliot-Gibson, V., Bogoch, E. R., Jamal, S. A., & Beaton, D. E. (2004). Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: A systematic review. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 15, 767–778. doi:10.1007/s00198-004-1675-5
   PubMed Web of Science ®Google Scholar
• Greenspan, S., Wyman, A. H., Hooven, F., Adami, S., Gehlbach, S., Anderson, F., Jr, & Watts, N. (2012). Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. Journal of the American Geriatrics Society, 60, 455–461. doi:10.1111/j.1532-5415.2011.03854.x
   PubMed Web of Science ®Google Scholar
• Hawley, S., Javaid, M. K., Priato-Alhambra, D., Lippet, J., Sheard, S., Arden, N. K., & Judge, A. (2016). .Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: Population-based longitudinal study. Age and Ageing, 45, 236–242. doi:10.1093/ageing/afv204
   PubMed Web of Science ®Google Scholar
• Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., & Kanis, J. A. (2013). Osteoporosis in the European Union: Medical management, epidemiology and economic burden. Archives of Osteoporosis, 8, 136–249. doi:10.1007/s11657-013-0136-1
   PubMed Web of Science ®Google Scholar
• Hochberg, M., Thompson, D., Black, D., Quandt, S., Cauley, J., Geusens, P., & Baran, D. (2005). Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. Journal of Bone and Mineral Research, 20, 971–976. doi:10.1359/JBMR.050104
   PubMed Web of Science ®Google Scholar
• Huntjens, K. M., van Geel, T. A., Blonk, M. C., Hegeman, J. H., van der Elst, M., Willems, P., & van Helden, S. H. (2011a). Implementation of osteoporosis guidelines: A survey of five large fracture liaison services in the Netherlands. Osteoporosis International, 22, 2129–2135.
   Google Scholar
• Huntjens, K. M., van Geel, T. A., van Den Bergh, J. P., van Helden, S., Willems, P., Winkens, B., & Brink, P. R. (2014). Fracture liaison service: Impact on subsequent nonvertebral fracture incidence and mortality. The Journal of Bone and Joint Surgery. American Volume, 96, e29. doi:10.2106/JBJS.M.00453
   PubMedGoogle Scholar
• Huntjens, K. M., van Geel, T. C., Geusens, P. P., Winkens, B., Willems, P., van Den Bergh, J., & van Helden, S. (2011b). Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fractures. Injury, 42, S39–43. doi:10.1016/S0020-1383(11)70011-0
   PubMed Web of Science ®Google Scholar
• Inderjeeth, C., Foo, A., Lai, M., & Glendenning, P. (2009). Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence. Bone, 44, 744–751. doi:10.1016/j.bone.2008.12.003
   PubMed Web of Science ®Google Scholar
• Ismail, A. A., O’Neill, T. W., Cockerill, W., Finn, J. D., Cannata, J. B., Hoszowski, K., & Silman, A. J. (2000). Validity of self-report of fractures: Results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int, 11, 248–254.
   PubMed Web of Science ®Google Scholar
• Lems, W. F., Dreinhöfer, K. E., Bischoff-Ferrari, H., Blauth, M., Czerwinski, E., Da Silva, J., & Geusens, P. (2017). EULAR/EFFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Annals of the Rheumatic Diseases, 76, 802–810. doi:10.1136/annrheumdis-2016-210289
   PubMed Web of Science ®Google Scholar
• Lih, A., Nandapalan, H., Kim, M., Yap, C., Lee, P., Ganda, K., & Seibel, M. J. (2011). Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: A 4-year prospective controlled study. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011(22), 849–858. doi:10.1007/s00198-010-1477-x
   Google Scholar
• McClung, M., Boonen, S., Törring, O., Roux, C., Rizzoli, R., Bone, H., & Cummings, S. (2012). Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis. Journal of Bone and Mineral Research, 27, 211–218. doi:10.1002/jbmr.536
   PubMed Web of Science ®Google Scholar
• McClung, M., Geusens, P., Miller, P. D., Zippel, H., BensenW., G., Roux, C., & Reginster, J. Y. (2001). Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. The New England Journal of Medicine, 344, 333–340. doi:10.1056/NEJM200102013440503
   PubMed Web of Science ®Google Scholar
• Melton, L. J., 3rd, Achenbach, S. J., Atkinson, E. J., Therneau, T. M., & Amin, S. (2013). Long-term mortality following fractures at different skeletal sites: A population-based cohort study. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013(24), 1689–1696. doi:10.1007/s00198-012-2225-1
   Google Scholar
• Nakayama, A., Major, G., Holliday, E., Attia, J., & Bogduk, N. (2016). Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporosis International : a Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27, 873–879. doi:10.1007/s00198-015-3443-0
   PubMed Web of Science ®Google Scholar
• van Geel, T., Huntjens, K., van Den Bergh, J., Dinant, G. J., & Geusens, P. (2010). Timing of subsequent fractures after an initial fracture. Current Osteoporosis Reports, 8, 118–122. doi:10.1007/s11914-010-0023-2
   PubMedGoogle Scholar
• Walters, S., Khan, T., Ong, T., & Sahota, O. (2017). Fracture liaison services: Improving outcomes for patients with osteoporosis. Clinical Interventions in Aging, 12, 117–127. doi:10.2147/CIA.S85551
   PubMed Web of Science ®Google Scholar